A team of researchers at the University of Twente (Netherlands) and German University in Cairo (Egypt) has developed sperm-inspired microrobots, which can be controlled by oscillating weak magnetic fields.
A team of Southern Nuclear engineers at the Edwin I. Hatch Nuclear Plant were honored yesterday at the Nuclear Energy Assembly in Phoenix, Ariz. They received the nuclear industry's highest honor – a TIP Award – for developing a Top Industry Practice. The team claimed the 2014 GE Hitachi Vendor Award for its participation in GE Hitachi's development of the Stinger™ Automated IVVI, a new first-of-a-kind tool for performing in-vessel visual inspections.
The development of light-driven 'micro-robots' that can autonomously investigate and manipulate the nano-scale environment in a microscope comes a step closer, thanks to new research from the University of Bristol.
Tauriga Sciences Inc. ("Tauriga" or "the Company"), a diversified life sciences company with key assets that include license agreements, topical medicinal cannabis lotions, and a proprietary technology platform in the nanorobotics space, is pleased to disclose to shareholders that the Company entered into the March 11, 2014 definitive merger agreement ("definitive agreement") with Oakland, California based Honeywood LLC ("Honeywood"), an affiliate of Doc Green's Healing Collective ("Doc Green's").
Xenex Disinfection Services, the world leader in UV room disinfection systems for healthcare facilities, today announced the availability of its HCAHPS Improvement Program, which is designed to help hospitals raise their Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) cleanliness scores.
Researchers at Brigham and Women's Hospital (BWH) and Carnegie Mellon University have introduced a unique micro-robotic technique to assemble the components of complex materials, the foundation of tissue engineering and 3D printing.
Tauriga Sciences, Inc. ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space, today announced the execution of a multi faceted service agreement ("the agreement") with the University of Cincinnati Research Institute ("UCRI") to facilitate the commercialization of the Company's proprietary bacterial robot ("BactoBot™") technology platform for treatment and remediation of wastewater.
Tauriga Sciences, Inc. ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space, today announced that its Pilus Energy LLC ("Pilus Energy") subsidiary has been selected as one of 50 Top Innovators to present at Venture Summit West 2014.
Tauriga Sciences, Inc. ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space, today completed the acquisition of Cincinnati, Ohio based synthetic biology pioneer Pilus Energy LLC ("Pilus Energy").
Tauriga Sciences, Inc. or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space, today highlighted the Genetic Rights Management ("GeRM") synthetic biology security system developed for Pilus Energy LLC ("Pilus Energy") to protect its proprietary BactoBots™ technology platform.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.